- Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, ‘Fat Loss’ Drug Prices. Barron’s
- Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs The Wall Street Journal
- Trump says Ozempic prices will be ‘much lower’ for Americans Fox Business
- Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s CNBC
- Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price Bloomberg.com
Source link
